UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________
FORM 8-K
_____________________
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
COMMISSION FILE NO.: 0-24185
Date of Report: July 6, 2006
CHINA AOXING PHARMACEUTICAL COMPANY, INC.
-----------------------------------------------------
(Exact name of registrant as specified in its charter)
Florida 65-0636168
---------------------------------------------------------------------
(State of other jurisdiction of (IRS Employer
incorporation or organization Identification No.)
100 Wall Street, 15th Floor, New York, NY 10005
---------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
(212) 232-0120 ext. 221
--------------------------------------------------
(Registrant's telephone number including area code)
Central American Equities Corp.
---------------------------------------------------------------------
(Former Name, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 5.03 Amendment to Articles of Incorporation
Effective on July 6, 2006, Central American Equities filed with the
Florida Department of State a Certificate of Amendment of its Certificate
of Incorporation. The amendment (1) changed the name of the corporation
to "China Aoxing Pharmaceutical Company, Inc." and (2) effected a reverse
stock split of the corporation's common stock in the ratio of 1:4.
Item 9.01 Financial Statements and Exhibits
Exhibits
3-a Certificate of Amendment of Certificate of Incorporation filed on
July 3, 2006, effective on July 6, 2006 at 6:00 p.m. Eastern
Standard Time.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
China Aoxing Pharmaceutical Company, Inc.
Dated: July 11, 2006 By: /s/ Zhenjiang Yue
--------------------------------------
Zhenjiang Yue, Chief Executive Officer